These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34077725)

  • 1. Pro-resolving lipid mediator lipoxin A
    Derada Troletti C; Enzmann G; Chiurchiù V; Kamermans A; Tietz SM; Norris PC; Jahromi NH; Leuti A; van der Pol SMA; Schouten M; Serhan CN; de Vries HE; Engelhardt B; Kooij G
    Cell Rep; 2021 Jun; 35(9):109201. PubMed ID: 34077725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
    Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
    Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
    Front Immunol; 2019; 10():2436. PubMed ID: 31681316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis.
    Weng WT; Kuo PC; Brown DA; Scofield BA; Furnas D; Paraiso HC; Wang PY; Yu IC; Yen JH
    J Neuroinflammation; 2021 May; 18(1):110. PubMed ID: 33975618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
    Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
    Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis.
    Sánchez-Fernández A; Zandee S; Mastrogiovanni M; Charabati M; Rubbo H; Prat A; López-Vales R
    J Neuroinflammation; 2022 Feb; 19(1):27. PubMed ID: 35109863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms regulating regional localization of inflammation during CNS autoimmunity.
    Pierson E; Simmons SB; Castelli L; Goverman JM
    Immunol Rev; 2012 Jul; 248(1):205-15. PubMed ID: 22725963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation.
    Xie L; Gong W; Chen J; Xie HW; Wang M; Yin XP; Wu W
    Int Immunopharmacol; 2018 Sep; 62():227-236. PubMed ID: 30031314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
    Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
    Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemically stable analogue of resolvin D1 ameliorates experimental autoimmune encephalomyelitis by mediating the resolution of inflammation.
    Zhang Q; Zhang Y; Zou M; Wu H; Liu C; Mi Y; Zhu J; Wang Y; Jin T
    Int Immunopharmacol; 2024 Oct; 140():112740. PubMed ID: 39116500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
    Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH
    Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hederagenol improves multiple sclerosis by modulating Th17 cell differentiation.
    Guan D; Li Y; Zhao X; Wang K; Guo Y; Dong N; Cui Y; Gao Y; Wang M; Wang J; Ren Y; Shang P; Liu Y
    IUBMB Life; 2024 Oct; 76(10):845-857. PubMed ID: 38838376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.
    Souza-Moreira L; Delgado-Maroto V; Morell M; O'Valle F; Del Moral RG; Gonzalez-Rey E
    Brain Behav Immun; 2013 May; 30():54-60. PubMed ID: 23376169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release.
    Abdelmoaty S; Wigerblad G; Bas DB; Codeluppi S; Fernandez-Zafra T; El-Awady el-S; Moustafa Y; Abdelhamid Ael-D; Brodin E; Svensson CI
    PLoS One; 2013; 8(9):e75543. PubMed ID: 24086560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
    Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
    Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A4 promotes experimental autoimmune encephalomyelitis by impacting microglial inflammation through TLR4/NF-κB signaling pathway.
    Jingjing H; Tongqian W; Shirong Y; Lan M; Jing L; Shihui M; Haijian Y; Fang Y
    Int Immunopharmacol; 2024 Dec; 142(Pt A):112849. PubMed ID: 39241524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bowman-Birk Inhibitor attenuates experimental autoimmune encephalomyelitis by delaying infiltration of inflammatory cells into the CNS.
    Dai H; Ciric B; Zhang GX; Rostami A
    Immunol Res; 2011 Dec; 51(2-3):145-52. PubMed ID: 22095543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Camelid-Derived STAT-Specific Nanobody Inhibits Neuroinflammation and Ameliorates Experimental Autoimmune Encephalomyelitis (EAE).
    Mbanefo EC; Seifert A; Yadav MK; Yu CR; Nagarajan V; Parihar A; Singh S; Egwuagu CE
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.